The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175
Open accessAbstract
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterized by motor, cognitive and psychiatric manifestations. Since the mutation responsible for the disease was identified as an unstable expansion of CAG repeats in the gene encoding the huntingtin protein in 1993, numerous mouse models of HD have been generated to study disease pathogenesis and evaluate potential therapeutic approaches. Of these, knock-in models best mimic the human condition from a genetic perspective since they express the mutation in the appropriate genetic and protein context. Behaviorally, however, while some abnormal phenotypes have been detected in knock-in mouse models, a model with an earlier and more robust phenotype than the existing models is required. We describe here for the first time a new mouse line, the zQ175 knock-in mouse, derived from a spontaneous expansion of the CAG copy number in our CAG 140 knock-in colony [1]. Given the inverse relationship typically observed between age of HD onset and length of CAG repeat, since this new mouse line carries a significantly higher CAG repeat length it was expected to be more significantly impaired than the parent line. Using a battery of behavioral tests we evaluated both heterozygous and homozygous zQ175 mice. Homozygous mice showed motor and grip strength abnormalities with an early onset (8 and 4 weeks of age, respectively), which were followed by deficits in rotarod and climbing activity at 30 weeks of age and by cognitive deficits at around 1 year of age. Of particular interest for translational work, we also found clear behavioral deficits in heterozygous mice from around 4.5 months of age, especially in the dark phase of the diurnal cycle. Decreased body weight was observed in both heterozygotes and homozygotes, along with significantly reduced survival in the homozygotes. In addition, we detected an early and significant decrease of striatal gene markers from 12 weeks of age. These data suggest that the zQ175 knock-in line could be a suitable model for the evaluation of therapeutic approaches and early events in the pathogenesis of HD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Neuropathological Classification of Huntingtonʼs Disease
VONSATTEL, J.-P., MYERS, R. H., STEVENS, T. J., FERRANTE, R. J., BIRD, E. D., & RICHARDSON, E. P. (1985) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198511000-00003 · Cited by 2,227
Andrew, S. E., Paul Goldberg, Y., Kremer, B., Telenius, H., Theilmann, J., Adam, S., Starr, E., Squitieri, F., Lin, B., Kalchman, M. A., et al. (1993) · Nature Genetics · doi:10.1038/ng0893-398 · Cited by 1,129
Using SAS PROC MIXED to Fit Multilevel Models, Hierarchical Models, and Individual Growth Models
Singer, J. D. (1998) · Journal of Educational and Behavioral Statistics · doi:10.2307/1165280 · Cited by 1,092
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Luthi-Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 720
Gray, M., Shirasaki, D. I., Cepeda, C., Andre, V. M., Wilburn, B., Lu, X.-H., Tao, J., Yamazaki, I., Li, S.-H., Sun, Y. E., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0857-08.2008 · Cited by 613
Application of a Method of Estimating DIF for Polytomous Test Items
Camilli, G., & Congdon, P. (1999) · Journal of Educational and Behavioral Statistics · doi:10.2307/1165366 · Cited by 607
Neurological abnormalities in a knock-in mouse model of Huntington's disease
Lin, C.-H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.137 · Cited by 592
Menalled, L. B., Sison, J. D., Dragatsis, I., Zeitlin, S., & Chesselet, M. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10776 · Cited by 536
Self-citationWhite, J. K., Auerbach, W., Duyao, M. P., Vonsattel, J.-P., Gusella, J. F., Joyner, A. L., & MacDonald, M. E. (1997) · Nature Genetics · doi:10.1038/ng1297-404 · Cited by 534
Delaying the onset of Huntington's in mice
van Dellen, A., Blakemore, C., Deacon, R., York, D., & Hannan, A. J. (2000) · Nature · doi:10.1038/35008142 · Cited by 511
Wheeler, V. C. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.503 · Cited by 469
Lione, L. A., Carter, R. J., Hunt, M. J., Bates, G. P., Morton, A. J., & Dunnett, S. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10428.1999 · Cited by 384
Transgenic rat model of Huntington's disease
von Horsten, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/12.6.617 · Cited by 359
Environmental enrichment slows disease progression in R6/2 Huntington's disease mice
Hockly, E., Cordery, P. M., Woodman, B., Mahal, A., Van Dellen, A., Blakemore, C., Lewis, C. M., Hannan, A. J., & Bates, G. P. (2002) · Annals of Neurology · doi:10.1002/ana.10094 · Cited by 330
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models
Menalled, L., El-Khodor, B. F., Patry, M., Suárez-Fariñas, M., Orenstein, S. J., Zahasky, B., Leahy, C., Wheeler, V., Yang, X. W., MacDonald, M., et al. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.007 · Cited by 324
Self-citationMouse models of Huntington's disease
Menalled, L. B., & Chesselet, M.-F. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01884-8 · Cited by 315
Self-citationSevere deficiencies in dopamine signaling in presymptomatic Huntington's disease mice
Bibb, J. A., Yan, Z., Svenningsson, P., Snyder, G. L., Pieribone, V. A., Horiuchi, A., Nairn, A. C., Messer, A., & Greengard, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120166397 · Cited by 289
Hickey, M. A., Kosmalska, A., Enayati, J., Cohen, R., Zeitlin, S., Levine, M. S., & Chesselet, M.-F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.041 · Cited by 226
Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course
Squitieri, F. (2003) · Brain · doi:10.1093/brain/awg077 · Cited by 203
Longitudinal Evaluation of theHdh(CAG)150Knock-In Murine Model of Huntington's Disease
Heng, M. Y., Tallaksen‐Greene, S. J., Detloff, P. J., & Albin, R. L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1830-07.2007 · Cited by 187
Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease
Augood, S. J., Faull, R. L. M., & Emson, P. C. (1997) · Annals of Neurology · doi:10.1002/ana.410420213 · Cited by 177
Hebb, A. L. O., Robertson, H. A., & Denovan-Wright, E. M. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.009 · Cited by 172
Denovan-Wright, E. M., & Robertson, H. A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00157-3 · Cited by 169
Woodman, B., Butler, R., Landles, C., Lupton, M. K., Tse, J., Hockly, E., Moffitt, H., Sathasivam, K., & Bates, G. P. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.11.004 · Cited by 166
BODY WEIGHT AND DIETARY FACTORS IN HUNTINGTON'S DISEASE PATIENTS COMPARED WITH MATCHED CONTROLS
Sanberg, P. R., Fibiger, H. C., & Mark, R. F. (1981) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1981.tb135681.x · Cited by 161 · cited 1×
“Loss of body weight is a progressive and characteristic symptom of HD [20].”
BackgroundKnock-in mouse models of Huntington’s disease
Menalled, L. (2005) · NeuroRx · doi:10.1602/neurorx.2.3.465 · Cited by 159
Self-citationChan, E. Y. W., Luthi‐Carter, R., Strand, A. D., Solano, S. M., Hanson, S., DeJohn, M. M., Kooperberg, C. L., Chase, K. O., DiFiglia, M., Young, A. B., et al. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1939 · Cited by 156
Early autophagic response in a novel knock-in model of Huntington disease
Heng, M. Y., Duong, D. K., Albin, R. L., Tallaksen‐Greene, S. J., Hunter, J. M., Lesort, M. J., Osmand, A., Paulson, H. L., & Detloff, P. J. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq285 · Cited by 138
Decrease in Striatal Enkephalin mRNA in Mouse Models of Huntington’s Disease
Menalled, L., Zanjani, H., Mackenzie, L., Koppel, A. B., Carpenter, E. M., Zeitlin, S., & Chesselet, M. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7327 · Cited by 133
Self-citationA retrospective study of the impact of lifestyle on age at onset of Huntington disease
Trembath, M. K., Horton, Z., Tippett, L. J., Hogg, V. M., Collins, V., Churchyard, A., Velakoulis, D., Roxburgh, R. H., & Delatycki, M. B. (2010) · Movement Disorders · doi:10.1002/mds.23108 · Cited by 121
McCaw, E. A., Hu, H., Gomez, G. T., Hebb, A. L. O., Kelly, M. E. M., & Denovan‐Wright, E. M. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04460.x · Cited by 106
Lloret, A., Dragileva, E., Teed, A. M., Espinola, J. A., Fossale, E., Gillis, T., Lopez, E., Myers, R. H., MacDonald, M. E., & Wheeler, V. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl125 · Cited by 105
Coordination of Prehensile Forces during Precision Grip in Huntington's Disease
Gordon, A. M., Quinn, L., Reilmann, R., & Marder, K. S. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7348 · Cited by 96
Reduced expression of preproenkephalin in striatal neurons from huntington's disease patients
Richfield, E. K., Maguire‐Zeiss, K. A., Cox, C., Gilmore, J., & Voorn, P. (1995) · Annals of Neurology · doi:10.1002/ana.410370309 · Cited by 86
Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system
Morton, A. J., Skillings, E. A., Bussey, T. J., & Saksida, L. M. (2006) · Nature Methods · doi:10.1038/nmeth1006-767 · Cited by 85
Hu, H., McCaw, E. A., Hebb, A. L. O., Gomez, G. T., & Denovan‐Wright, E. M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03796.x · Cited by 78
Longitudinal analysis of the behavioural phenotype in HdhQ92 Huntington's disease knock-in mice
Brooks, S. P., Higgs, G. V., Jones, L., & Dunnett, S. B. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.05.003 · Cited by 71
The use of transgenic and knock-in mice to study Huntington’s disease
Hickey, M. A., & Chesselet, M.-F. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072863 · Cited by 69
Benn, C., Fox, H., & Bates, G. P. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-17 · Cited by 68
Albin, R. L., Qin, Y., Young, A. B., Penney, J. B., & Chesselet, M. (1991) · Annals of Neurology · doi:10.1002/ana.410300406 · Cited by 66
Selective extra-dimensional set shifting deficit in a knock-in mouse model of Huntington's disease
Brooks, S. P., Betteridge, H., Trueman, R. C., Jones, L., & Dunnett, S. B. (2006) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2006.02.011 · Cited by 43
Rising, A. C., Xu, J., Carlson, A. M., Napoli, V. V., Denovan‐Wright, E. M., & Mandel, R. J. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.12.017 · Cited by 40
Disturbances of precision grip in Huntington's disease
Fellows, S. J., Schwarz, M., Schaffrath, C., Dömges, F., & Noth, J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00264-4 · Cited by 38
Cited by
Tong, X., Ao, Y., Faas, G. C., Nwaobi, S. E., Xu, J., Haustein, M. D., Anderson, M. A., Mody, I., Olsen, M. L., Sofroniew, M. V., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3691 · Cited by 592
Elusive roles for reactive astrocytes in neurodegenerative diseases
Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453
Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice
Langfelder, P., Cantle, J. P., Chatzopoulou, D., Wang, N., Gao, F., Al-Ramahi, I., Lu, X.-H., Ramos, E. M., El-Zein, K., Zhao, Y., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4256 · Cited by 385
Self-citationCystathionine γ-lyase deficiency mediates neurodegeneration in Huntington’s disease
Paul, B. D., Sbodio, J. I., Xu, R., Vandiver, M. S., Cha, J. Y., Snowman, A. M., & Snyder, S. H. (2014) · Nature · doi:10.1038/nature13136 · Cited by 404
Choosing an animal model for the study of Huntington's disease
Pouladi, M. A., Morton, A. J., & Hayden, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3570 · Cited by 356
Metadata
- Authors
- Menalled, L. B., Kudwa, A. E., Miller, S., Fitzpatrick, J., Watson-Johnson, J., Keating, N., Ruiz, M., Mushlin, R., Alosio, W., McConnell, K., Connor, D., Murphy, C., Oakeshott, S., Kwan, M., Beltran, J., Ghavami, A., Brunner, D., Park, L. C., Ramboz, S., & Howland, D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-20
- Volume
- 7
- Issue
- 12
- Pages
- e49838
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2048323087
- Cited by
- 469
- References
- 45
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.